SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 194 filers reported holding SEATTLE GENETICS INC in Q2 2014. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $191,715,000 | +68.1% | 1,128,264 | +14.1% | 0.33% | +35.2% |
| Q1 2020 | $114,081,000 | +30.3% | 988,747 | +29.1% | 0.24% | +57.4% |
| Q4 2019 | $87,540,000 | -23.3% | 766,148 | -42.6% | 0.16% | +29.2% |
| Q3 2019 | $114,064,000 | +197.4% | 1,335,652 | +141.0% | 0.12% | +44.6% |
| Q2 2019 | $38,354,000 | -38.2% | 554,163 | -34.6% | 0.08% | -39.4% |
| Q1 2019 | $62,070,000 | +30.2% | 847,492 | +0.7% | 0.14% | +14.2% |
| Q4 2018 | $47,674,000 | +49.4% | 841,411 | +103.3% | 0.12% | +79.1% |
| Q3 2018 | $31,917,000 | -27.5% | 413,863 | -37.6% | 0.07% | -36.2% |
| Q2 2018 | $44,052,000 | +7.0% | 663,530 | -15.6% | 0.10% | +2.9% |
| Q1 2018 | $41,156,000 | -34.9% | 786,323 | -33.5% | 0.10% | -37.4% |
| Q4 2017 | $63,264,000 | -8.2% | 1,182,508 | -6.6% | 0.16% | -16.4% |
| Q3 2017 | $68,906,000 | +52.5% | 1,266,426 | +79.3% | 0.20% | +40.3% |
| Q2 2017 | $45,190,000 | +51.1% | 706,316 | +48.4% | 0.14% | +41.8% |
| Q1 2017 | $29,910,000 | +1571.9% | 475,824 | +1303.6% | 0.10% | +1300.0% |
| Q4 2016 | $1,789,000 | -68.5% | 33,900 | -73.2% | 0.01% | -70.8% |
| Q4 2015 | $5,675,000 | +22.9% | 126,450 | +5.6% | 0.02% | +20.0% |
| Q3 2015 | $4,618,000 | -13.3% | 119,750 | +7.6% | 0.02% | -9.1% |
| Q2 2015 | $5,326,000 | +43.6% | 111,250 | +3.0% | 0.02% | +46.7% |
| Q1 2015 | $3,710,000 | +30.3% | 108,050 | +21.9% | 0.02% | +15.4% |
| Q4 2014 | $2,848,000 | +79.2% | 88,650 | +107.4% | 0.01% | +62.5% |
| Q3 2014 | $1,589,000 | -8.0% | 42,750 | -5.3% | 0.01% | 0.0% |
| Q2 2014 | $1,727,000 | +32.3% | 45,150 | +57.6% | 0.01% | +14.3% |
| Q1 2014 | $1,305,000 | +10.7% | 28,650 | -3.0% | 0.01% | +16.7% |
| Q4 2013 | $1,179,000 | -9.3% | 29,550 | -0.3% | 0.01% | -14.3% |
| Q3 2013 | $1,300,000 | +43.5% | 29,650 | +3.0% | 0.01% | +40.0% |
| Q2 2013 | $906,000 | – | 28,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |